Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Acute Pain

In brief

This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.

Key facts

Study ID

NCT06184126

Run by

University of Maryland, Baltimore

People needed

30

Starts

2024-11-01

Expected to finish

2026-12-31

Last updated by the study team

2025-12-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (age > 18 years) emergency department patient
• History of sickle cell disease
• Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis

You may not qualify if…

• Prior enrollment in this study
• Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
• Not being treated with intravenous opioids for the vaso-occlusive crisis
• Patients who lack the capacity to provide informed consent
• Medical history of seizures or known intolerance to virtual reality
• Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device.
• Known to be pregnant
• Incarcerated at the time of evaluation
• Over the age of 89 years old

Where it is running

• University of Maryland Medical Systems — Baltimore, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.